StockWatch
·
Q2 FY-2027 RESULTS · COLPAL

Colgate Q2 FY27: revenue +12% YoY, PAT +4% as A&P jumps 40%, margins compress ~290bps

PAT +4.29% YoY · revenue +12.26% · margins compressing

Q2 FY27 resultsCOLPALCOLGATE-PALMOLIVE (INDIA) LTD.22 Oct 2026 · 3 min read
Revenue

₹1,705.79 Cr

+12.26% YoY

PAT (standalone)

₹341.57 Cr

+4.29% YoY

Net margin

19.77%

-1.6pp YoY

EPS

₹12.56

Colgate-Palmolive India's standalone Q2 FY27 (quarter ended September 30, 2026) revenue from operations came in at ₹1,705.79 Cr, up 12.3% YoY and 6.4% QoQ — a second straight quarter of double-digit top-line growth after Q1 FY27's 11.8%. But profit growth badly lagged: PAT of ₹341.57 Cr (EPS ₹12.56) rose just 4.3% YoY and actually slipped 0.4% QoQ from ₹343.08 Cr, with no exceptional items in either the current or year-ago quarter to distort the comparison — this is a genuine, operating-level growth-to-profit gap, not a base-effect or one-off artifact.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹1,705.79 Cr+6.4%+12.3%
Expenses₹1,267.28 Cr+9.2%+16%
PAT₹341.57 Cr-0.44%+4.29%
Net margin19.77%-1.3pp-1.6pp
EPS₹12.56-0.4%+4.3%

The gap sits squarely in margins: net profit margin fell to 19.8% of total income from 21.3% a year ago and 21.1% last quarter (a ~150bps YoY compression), while operating margin (EBITDA/revenue-from-operations) eased to roughly 27.8% from ~30.6% YoY and ~29.9% QoQ. The driver is advertising: A&P spend jumped 39.9% YoY and 25.0% QoQ to ₹314.82 Cr, taking A&P intensity to ~18.5% of revenue — above the ~15.8% level (up from 12-13%) management flagged on the August 2026 concall as the new normal for absorbing premiumisation-led brand investment. Employee costs also rose a faster 15.1% YoY, adding to the squeeze, while cost of materials grew a more moderate 9.2% YoY.

₹
1,627.231,776.471,925.72,074.932,224.171,68507-2008-1109-0209-2510-2110-22Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,685, down 10.9% over the past month of trading.

₹ Cr
0131.91263.81395.72320.62Q1 FY26rev ₹1,434 Cr327.51Q2 FY26rev ₹1,520 Cr323.86Q3 FY26rev ₹1,486 Cr353.32Q4 FY26rev ₹1,595 Cr343.08Q1 FY27rev ₹1,603 Cr341.57Q2 FY27rev ₹1,706 Cr
Quarterly standalone PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
Management targets sustained double-digit growth via balanced volume/price/mix with upward bias on premiumisation spend. Gross margins to remain 'in range'; EBITDA to absorb higher A&P (15.8%, up from 12-13%). No numeric FY27 revenue or PAT targets provided.

— This quarter: met

Against management's own prior guidance — sustained double-digit growth via volume/price/mix, margins absorbing higher A&P — this quarter is a clean match: growth delivered, and A&P ran even hotter than the 15.8% marker, so the compression reflects the plan playing out rather than a miss. No formal numeric consensus for this specific quarter turned up in public previews, so vsStreet is marked unknown; the broader brokerage tone (Goldman Sachs and Citi have held Sell ratings through 2026) has flagged exactly these margin and competitive-intensity concerns. It's also worth noting the YoY base is soft: Q2 FY26 PAT itself had fallen 17.1% YoY on GST-transition distributor disruption, so this year's +4.3% YoY sits on a depressed prior-year print. Alongside the results, the board declared a first interim dividend of ₹24/share (₹652.77 Cr aggregate, record date November 2, 2026), and separately the company saw a marketing leadership change — EVP-Marketing Gunjit Jain resigns effective November 30, succeeded by Akash Parekh from December 1 — landing just as A&P investment is being stepped up. No standalone press-release commentary from management was available in the filing to cross-check against the numbers.

  • W1

    A&P intensity trajectory — guided to ~15.8% of revenue (from 12-13%); actual hit ~18.5% this quarter — watch whether Q3 FY27 holds near this level or normalizes down.

  • W2

    Whether double-digit revenue growth (12.3% this quarter, 11.8% in Q1 FY27) sustains into H2 FY27 as the base normalizes from last year's GST-disruption-hit Q2 FY26.

  • W3

    Leadership transition — new EVP-Marketing Akash Parekh takes over December 1, 2026, and MD&CEO Manish Anandani's formal appointment goes to shareholder postal ballot (cut-off October 23, 2026).

Standalone only — company has no subsidiary/JV (Note 7); single reportable segment 'Personal Care' so no segment breakout (Note 6); source figures in ₹ Lakh converted to Crore (÷100); no exceptional items this quarter or year-ago quarter (Nil both), so raw and underlying YoY PAT growth are identical.

Informational and educational content only. Not investment advice.